Not Just NE Cancer
Neuroendocrine Cancer Treatments: Insights from Jane and Carolyn
In this episode of the Not Just NE Cancer podcast, Cathy speaks with Jane and Carolyn about their experiences with neuroendocrine cancer treatment.
Jane discusses her journey with CAPTEM, PRRT and now four-weekly Lanreotide, while Carolyn shares her story of initially receiving chemotherapy (wrongly), then moving to a watch-and-wait approach, Lanreotide, and finally PRRT through a clinical trial. They delve into accessing these treatments, managing side effects, and the level of autonomy patients have over their treatment options. Tune in for their insightful experiences and perspectives.
Further Support:
In this episode of the Not Just NE Cancer podcast, Cathy speaks with Jane and Carolyn about their experiences with neuroendocrine cancer treatment.
Jane discusses her journey with CAPTEM, PRRT and now four-weekly Lanreotide, while Carolyn shares her story of initially receiving chemotherapy (wrongly), then moving to a watch-and-wait approach, Lanreotide, and finally PRRT through a clinical trial. They delve into accessing these treatments, managing side effects, and the level of autonomy patients have over their treatment options. Tune in for their insightful experiences and perspectives.
Further Support: